The Japanese Pharmacopoeia (日本薬局方) is the official pharmacopoeia of Japan.
It is published by the Pharmaceuticals and Medical Devices Agency (独立行政法人 医薬品医療機器総合機構, Dokuritsu-gyōsei hōjin iyakuhin-iryō-kiki-sōgō-kikō).
The first edition was published on 25 June 1886, with revisions being issued from time to time. The current revision is number 18, issued electronically on 07 June 2021.
An official English translation is in preparation (status: 06 August 2021).
Refer to The International Pharmacopoeia, British Pharmacopoeia, European Pharmacopoeia, United States Pharmacopoeia, Indian Pharmacopoeia Commission, Japanese Pharmacopoeia, and Pharmacopoeia of the People’s Republic of China.
This page is based on the copyrighted Wikipedia article < https://en.wikipedia.org/wiki/Japanese_Pharmacopoeia >; it is used under the Creative Commons Attribution-ShareAlike 3.0 Unported License (CC-BY-SA). You may redistribute it, verbatim or modified, providing that you comply with the terms of the CC-BY-SA.
7 thoughts on “What is the Japanese Pharmacopoeia?”